Format

Send to

Choose Destination
See comment in PubMed Commons below
Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):615-21. doi: 10.1161/ATVBAHA.107.158154. Epub 2008 Jan 10.

CD47: a new target in cardiovascular therapy.

Author information

1
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Abstract

CD47, originally named integrin-associated protein, is a receptor for thrombospondin-1. A number of important roles for CD47 have been defined in regulating the migration, proliferation, and survival of vascular cells, and in regulation of innate and adaptive immunity. The recent discovery that thrombospondin-1 acts via CD47 to inhibit nitric oxide signaling throughout the vascular system has given new importance and perhaps a unifying mechanism of action to these enigmatic proteins. Here we trace the development of this exciting new paradigm for CD47 function in vascular physiology.

PMID:
18187671
PMCID:
PMC2553319
DOI:
10.1161/ATVBAHA.107.158154
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center